Company Overview

Update
Status:
Acquired by AstraZeneca
Founders:
Michael H. Davidson, Jerry Wisler
Headquarters:
Princeton, NJ
IPO:
Went Public on Apr 11, 2013
Stock:
OMTH
Categories:
Health and Wellness, Medical, Pharmaceuticals, Biotechnology
Description:
Omthera Pharmaceuticals develops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease.

Detailed Description

Update

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Current Team (3)

Update

Funding Rounds (4) - $60.2M

Update

Board Members and Advisors (3)

Update

Investors (2)

Update
  • E5e00ec4ecc92739b01aeee0458c3b9b

    Sofinnova Partners

    Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35...
  • 273543c3bce9d00153ff348aa8929383

    New Enterprise Associates

    Global venture capital firm helping entrepreneurs build transformational businesses across...

Offices/Locations (1)

Update
  • Headquarters

    707 State Road

    Princeton, NJ 08540

    USA

Images (1)

Update
  • Aaa8eaf71dc0cd02c77c95c332177b03